VitaNova Life Sciences (VNOV) EBIT Margin (2017 - 2026)
VitaNova Life Sciences (VNOV) reported EBIT Margin of 6.59% for Q1 2026, down 2873.0% on a YoY basis from 0.24% in Q1 2025, and down 71.64% quarter-over-quarter from 23.22% in Q4 2025.
VitaNova Life Sciences (VNOV) EBIT Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences has reported EBIT Margin for 7 years, with the latest figure at 6.59% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 2873.0% year-over-year to 6.59%; the trailing twelve-month figure through Jan 2026 stood at 37.44% (up 882.0% YoY), and the FY2025 full-year result was 45.39%, up 936.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 6.59%, down from 23.22% in the prior quarter.
- The five-year high for EBIT Margin was 83.91% in Q1 2022, with the low at 245.77% in Q1 2023.
- Historically, EBIT Margin has averaged 8.61% across 5 years, with a median of 21.43% in 2024.
- Annual changes were most pronounced in 2023 — EBIT Margin plunged 32968 bps — and 2024, when it surged 26856 bps.
- VitaNova Life Sciences' EBIT Margin stood at 26.01% in 2022, then sank by 662 bps to 146.17% in 2023, then jumped by 115 bps to 21.43% in 2024, then rose by 8 bps to 23.22% in 2025, then slumped by 72 bps to 6.59% in 2026.
- The last three EBIT Margin figures came in at 6.59% (Q1 2026), 23.22% (Q4 2025), and 31.22% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.46% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 2.73% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.01% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -12.18% |
| 10 | VitaNova Life Sciences | - | - | 316,343.00 | 6.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 6.59% |
| Oct 31, 2025 | 23.22% |
| Jul 31, 2025 | -31.22% |
| Apr 30, 2025 | 55.41% |
| Jan 31, 2025 | 35.31% |
| Oct 31, 2024 | 21.43% |
| Jul 31, 2024 | -41.87% |
| Apr 30, 2024 | 42.73% |
| Jan 31, 2024 | 22.79% |
| Apr 30, 2023 | -146.17% |
| Jan 31, 2023 | -245.77% |
| Oct 31, 2022 | 26.01% |
| Jul 31, 2022 | 14.23% |
| Apr 30, 2022 | 4.30% |
| Jan 31, 2022 | 83.91% |
| Oct 31, 2021 | -66.65% |
| Jul 31, 2017 | 116.47% |